Clinical Trials Logo

Recurrent Malignant Mesothelioma clinical trials

View clinical trials related to Recurrent Malignant Mesothelioma.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01861301 Terminated - Clinical trials for Recurrent Malignant Mesothelioma

Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

Start date: January 2013
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well tivantinib works in treating patients with previously treated malignant mesothelioma. Tivantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT00028782 Terminated - Clinical trials for Primary Peritoneal Cavity Cancer

EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer

Start date: October 2001
Phase: N/A
Study type: Interventional

This phase II trial is studying how well EF5 works in detecting oxygen level and blood vessels in tumor cells of patients who are undergoing photodynamic therapy for intraperitoneal or pleural cancer. Diagnostic procedures using EF5 to detect oxygen level and blood vessels in tumor cells may help to improve the way photodynamic therapy is given